BioInvent International AB (publ) (BINV.ST) - Stock Prices, Stock Peers & Analysis

Home
BINV.ST

Company Name	BioInvent International AB (publ)
Symbol	BINV.ST
Currency	SEK
Price	16.58
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,091,036,952
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	14 - 32
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Martin Welschof Ph.D.
Website	https://www.bioinvent.com

An error occurred while fetching data.

About BioInvent International AB (publ)

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells;